
At a Glance
Frist Cressey Ventures is the venture capital arm of Frist Cressey, a healthcare-focused private equity firm founded by the Frist family. The venture arm was established in 2018 to focus on earlier-stage healthcare technology investments, complementing the parent firm's growth equity strategy. The firm leverages decades of healthcare industry expertise and an extensive network of healthcare executives, providers, and operators built through Frist Cressey's long history in the sector. FCV typically invests $1-10 million in seed through Series B rounds, targeting companies developing innovative solutions in digital health, healthcare services, medical devices, and health IT. The team is led by experienced healthcare investors who work closely with portfolio companies to accelerate growth through strategic partnerships, customer introductions, and operational guidance. What distinguishes FCV is their deep healthcare domain expertise combined with access to Frist Cressey's broader platform of resources, including relationships with major health systems, payers, and healthcare service providers.
“Healthcare-focused venture capital firm investing in innovative medical technologies, digital health solutions, and healthcare services companies.”
Frist Cressey Ventures primarily invests at the Pre-Seed, Seed, Series A, Series B+ stages. This means they focus on companies that are at the earliest idea or prototype phase.
Frist Cressey Ventures is headquartered in Chicago, IL. Many of their portfolio companies are also based in this region, though they invest across geographies.
Frist Cressey Ventures focuses on investments in Aerospace & Defense, Digital Health, Other, Consumer, Fintech. Their portfolio reflects deep expertise and networks within these sectors.
Frist Cressey Ventures's typical investment check size ranges from $500K to $20M. Actual amounts may vary based on the stage, sector, and specific opportunity.
Frist Cressey Ventures manages approximately $200M in assets under management (AUM) across their funds.